These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28003122)

  • 1. Metronomic chemotherapy: A relook at its basis and rationale.
    Rajasekaran T; Ng QS; Tan DS; Lim WT; Ang MK; Toh CK; Chowbay B; Kanesvaran R; Tan EH
    Cancer Lett; 2017 Mar; 388():328-333. PubMed ID: 28003122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance.
    Kareva I; Waxman DJ; Lakka Klement G
    Cancer Lett; 2015 Mar; 358(2):100-106. PubMed ID: 25541061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
    Rasmussen RM; Kurzman ID; Biller BJ; Guth A; Vail DM
    Vet Comp Oncol; 2017 Jun; 15(2):421-430. PubMed ID: 26522053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
    Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
    Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic chemotherapy and nanocarrier platforms.
    Abu Lila AS; Ishida T
    Cancer Lett; 2017 Aug; 400():232-242. PubMed ID: 27838415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic therapy: chemotherapy revisited.
    Noronha V; Krishna MV; Patil V; Joshi A; Banavali SD; Prabhash K
    Indian J Cancer; 2013; 50(2):142-8. PubMed ID: 23979206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules.
    Banchi M; Cox MC; Bocci G
    Cancer Lett; 2024 Jun; 591():216900. PubMed ID: 38636896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomics chemotherapy: time for computational decision support.
    Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.
    Benzekry S; Hahnfeldt P
    J Theor Biol; 2013 Oct; 335():235-44. PubMed ID: 23850479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic therapy in pediatric oncology: A snapshot.
    Pramanik R; Bakhshi S
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27811. PubMed ID: 31207063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic therapy concepts in the management of adrenocortical carcinoma.
    Berruti A; Sperone P; Bellini E; Daffara F; Perotti P; Ardito A; Saini A; Terzolo M
    Horm Cancer; 2011 Dec; 2(6):378-84. PubMed ID: 21971765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.
    Gaspar TB; Henriques J; Marconato L; Queiroga FL
    Vet Comp Oncol; 2018 Mar; 16(1):2-11. PubMed ID: 28317239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?
    André N; Tsai K; Carré M; Pasquier E
    Trends Cancer; 2017 May; 3(5):319-325. PubMed ID: 28718409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All.
    André N; Orbach D; Pasquier E
    Trends Cancer; 2020 Oct; 6(10):819-828. PubMed ID: 32601045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic chemotherapy and immunotherapy in cancer treatment.
    Chen YL; Chang MC; Cheng WF
    Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.
    Launay S; Sabatier R; Brunelle S; Esterni B; Tarpin C; Viret F; Gravis G; Cappiello M; Provansal M; Extra JM; Bertucci F; Viens P; Goncalves A
    Anticancer Res; 2016 Jan; 36(1):293-9. PubMed ID: 26722056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomics: towards personalized chemotherapy?
    André N; Carré M; Pasquier E
    Nat Rev Clin Oncol; 2014 Jul; 11(7):413-31. PubMed ID: 24913374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic chemotherapy in cancer treatment: new wine in an old bottle.
    Wu HL; Zhou HX; Chen LM; Wang SS
    Theranostics; 2024; 14(9):3548-3564. PubMed ID: 38948068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.